Junjie Q. Liu

1095 Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

A 1 kV Compensation-Free Three-Stage Inductive Voltage Divider with Integrated-Reference Self-Calibration.

A 1 kV Compensation-Free Three-Stage Inductive Voltage Divider with Integrated-Reference Self-Calibration.

Journal: Sensors (Basel, Switzerland)

Published: June 10, 2026

A novel method combined with self-calibration and statistical process control for evaluating the state of merging unit.

A novel method combined with self-calibration and statistical process control for evaluating the state of merging unit.

Journal: The Review of scientific instruments

Published: January 23, 2026

Tumor-Induced Rewiring of Splenic Niches: from Immune Organ to Cancer Accomplice.

Tumor-Induced Rewiring of Splenic Niches: from Immune Organ to Cancer Accomplice.

Journal: International journal of biological sciences

Published: October 22, 2025

Prognostic model for unresectable hepatocellular carcinoma treated with transarterial therapy plus TKIs and anti-PD-1 antibodies.

Prognostic model for unresectable hepatocellular carcinoma treated with transarterial therapy plus TKIs and anti-PD-1 antibodies.

Journal: World journal of surgical oncology

Published: September 26, 2025

Impact of Cytokeratin 19 Expression on the Outcomes of Unresectable Hepatocellular Carcinoma Treated with Targeted Therapy and Immunotherapy: A Propensity Score Matched Analysis.

Impact of Cytokeratin 19 Expression on the Outcomes of Unresectable Hepatocellular Carcinoma Treated with Targeted Therapy and Immunotherapy: A Propensity Score Matched Analysis.

Journal: Journal of hepatocellular carcinoma

Published: July 21, 2025

Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D.

Pathogenesis, prevention, and therapeutic advances in hepatitis B, C, and D.

Journal: Virology journal

Published: June 17, 2025

Amphiregulin: a potential therapeutic target for tissue fibrosis.

Amphiregulin: a potential therapeutic target for tissue fibrosis.

Journal: Trends in pharmacological sciences

Published: April 18, 2025

ITLN1, orchestrated by the IFNγ-IRF1 axis, suppresses hepatocellular carcinoma proliferation via ERK1/2 activation.

ITLN1, orchestrated by the IFNγ-IRF1 axis, suppresses hepatocellular carcinoma proliferation via ERK1/2 activation.

Journal: Translational oncology

Published: March 07, 2025

Nurses' preferences for interventions to improve infection prevention and control behaviors based on systems engineering initiative to patient safety model: a discrete choice experiment.

Nurses' preferences for interventions to improve infection prevention and control behaviors based on systems engineering initiative to patient safety model: a discrete choice experiment.

Journal: BMC nursing

Published: September 20, 2023

Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy.

Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy.

Journal: Cancer letters

Published: June 27, 2023

Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy.

Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy.

Journal: Frontiers in immunology

Published: July 12, 2022

Perioperative outcomes of robot-assisted versus laparoscopic liver resection for cavernous hemangioma: a propensity score matching study.

Perioperative outcomes of robot-assisted versus laparoscopic liver resection for cavernous hemangioma: a propensity score matching study.

Journal: Surgical endoscopy

Published: May 22, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026